Adults (18-65), Geriatrics (65+)
There is no publicly available rating for this medical professional for one of the following reasons:
Adults (18-65), Geriatrics (65+)
Critical Care Medicine, 2018
Internal Medicine, 2013
Pulmonary Disease, 2016
Perelman Center for Advanced Medicine
West Pavilion, 1st Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
J.C. Thompson, R. Fan, T. Black, G.H. Yu, S.L. Savitch, A. Chien, S. Yee, M. Sen, W. Hwang, S.I. Katz, M. Feldman, A. Vachani, E.L. Carpenter.: Measurement and Immunophenotyping of pleural EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients. Lung Cancer 127 : 25-33,2019.
C. Aggarwal*, J.C Thompson*, T. Black, S. Katz, R. Fan, S.S Yee, A. Chien, T.L. Evans, J. Bauml, E. Alley, C. Ciunci, A. Berman, R. Cohen, D. Lieberman, K. Majmundar, S.L Savitch, J.D. Morrissette, W. Hwang, K. Elenitoba-Johnson, C.J. Langer, E.L. Carpenter.: Clinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non–small cell lung cancer. JAMA Oncology 5 (2): 173-180,2019.
C. Aggarwal, C. Davis, R. Mick, J.C. Thompson, S. Ahmed, S. Jeffries, S. Bagley, P. Gabriel, T.L. Evans, J. Bauml, C. Ciunci, E. Alley, J.D. Morrissette, R. Cohen, E.L. Carpenter, C. Langer: Influence of TP53 Mutation on Survival and Transformation to Small Cell Lung Cancer in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer JCO Precision Oncology published on line : 2018.
S. Katz, M. Hammer, S.J. Bagley, C. Aggarwal, J. Bauml, J.C. Thompson, A.C. Nachiappan, C.B. Simone, C. Langer.: Radiologic pseudoprogression during anti-PD1 therapy for advanced non-small lung cancer. J Thorac Oncol.
13 (7): 978-986,2018.
A. Klampatsa, S. O’Brien, E. Eruslanov, A. Rao, J.C. Thompson, S. Kim, K. Cengel, E. Moon, S. Singhal, S. Albelda: Phenotypic and Functional Analysis of Malignant Mesothelioma Tumor-Infiltrating Lymphocytes (TILs). Internal Conference of the International Mesothelioma Interest Group. Ottawa, Canada. : 2018.
E. Moon. S. O’brien, J.C. Thompson, S. Kim, K. Ma, D. Dibardino. A. Lanfranco, A. Vachani, A. Haas, S. Albelda.: A Pilot study of endobronchial guided transbronchial needle aspiration for immunophenotyping the lung cancer tumor microenvironment. American Thoracic Society Conference. San Diego, CA. : 2018.
J.C.Thompson, S.L. Savitch, R. Fan, S.S Yee, C.A. Powers, G. Yu, L. Gebrian, D. Smirnov, C. Rao, S. Gross, M. Feldman, A. Vachani, E.L. Carpenter: The use of circulating tumor cell technology for the characterization of tumor cells and assessment of PD-L1 expression in pleural effusions of metastatic non-small cell lung cancer patients. Association of Clinical and Translational Science. Washington, D.C. : 2018.
E. Bange*, M. Marmarelis*, W. Hwang, Y. Yang, J.C. Thompson, J. Bauml, C.Ciunci, E. Alley, T. Evans, J. Morrissette, R. Cohen, C. Langer, E. Carpenter, C. Aggarwal.: Impact of KRAS and TP53 co-mutations on outcomes following 1st-line therapy among patient with LKB1/STK11 mutated stage IV NSCLC. American Association for Cancer Research Annual Meeting, Chicago, IL.
M. Marmarelis, J.C. Thompson, C. Aggarwal, T.L. Evans, E. Carpenter. R.B. Cohen, C.J. Langer, J. Bauml.: Emerging uses of circulating tumor DNA in advanced stage non-small cell lung cancer.
Ann Transl Med.
5 (18): 380,2017.
S.J. Bagley, S. Kothari, C. Aggarwal, J. Bauml, E. Alley, T.L Evans, J.A. Kosteva, C. Ciunci, J.C. Thompson, S. Stonehouse-Lee, V.E. Sherry, E. Gilbert, B. Sandy, F. Mutale, G. DiLullo, R.B. Cohen, A. Vachani, C. Langer.: Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab treated patients with advanced non-small cell lung cancer. Lung Cancer 106 : 1-7,2017.
DE Schwed Lustgarten, J.C. Thompson, G Yu, A Vachani, B Vaidya, C Rao, M Connelly, M Udine, KS Tan, D. Heitjan, S Albelda: Use of circulating tumor cell technology (CELLSEARCH) for the diagnosis of malignant pleural effusions. Annals of the American Thoracic Society 10 (6): 582-9,2013.
J. C. Thompson, S.S Yee, A.B. Troxel, S.L. Savitch, R. Fan, D. Balli, D.B. Lieberman, J.D Morrissette, T.L Evans, J. Bauml, C. Aggarwal, J.A Kosteva, E. Alley, C. Ciunci, R.B. Cohen, S. Bagley, S. Stonehouse-Lee, V.E. Sherry, E. Gilbert, C. Langer, A. Vachani, E. Carpenter: Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA. Clinical Cancer Research 22 (23): 5772-5782,2016.
221 Stemmler Hall3450 Hamilton Walk
Phone: (215) 898-3168
Patient appointments: 800-789-7366
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.